Euro
USD
British Pound
NULL
Product Description
Potent, broad spectrum matrix metalloprotease (MMP) inhibitor (IC₅₀ values are 3, 4, 4, 6 and 20 nM for MMP -1, -2, -9, -7 and -3 respectively). Exhibits antiproliferative, anti-invasive and antimetastatic activity in human ovarian carcinoma xenografts in vivo.
EZSolution™ Batimastat is a A 10 mM (1 mg in 209 µl) of the MMP inhibitor Batimastat (Cat. No.1704) in anhydrous DMSO.
Biovision | 2540 | EZSolution™ Batimastat DataSheet
Alternate Name/Synonyms: BB94; (2R,3S)-N4-Hydroxy-N1-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]butanediamide
Appearance: Liquid
Formulation: A 10 mM solution in anhydrous DMSO
CAS Number: 130370-60-4
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₂₃H₃₁N₃O₄S₂
Molecular Weight: 477.64
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: N/A
Handling: Protect from air and moisture
Country of Origin: USA
Tag Line: A broad spectrum matrix metalloprotease (MMP) inhibitor
MDL Number: MFCD00866533
PubChem CID: 5362422
SMILES: CC(C)CC(C(CSC1=CC=CS1)C(=O)NO)C(=O)NC(CC2=CC=CC=C2)C(=O)NC
InChi: InChI=1S/C23H31N3O4S2/c1-15(2)12-17(18(22(28)26-30)14-32-20-10-7-11-31-20)21(27)25-19(23(29)24-3)13-16-8-5-4-6-9-16/h4-11,15,17-19,30H,12-14H2,1-3H3,(H,24,29)(H,25,27)(H,26,28)/t17-,18+,19+/m1/s1
InChi Key: XFILPEOLDIKJHX-QYZOEREBSA-N
